Gabather

Gabather is a clinical-stage pharmaceutical company aimed at transforming the treatment of neuropsychiatric disorders. The company was founded to address significant unmet needs and the lack of innovative therapies in the field of mental health treatment. Gabather is committed to developing novel drugs for several diseases originating in the central nervous system. It has four primary areas of focus: antipsychotics, antidepressants and anxiolytics, analgesics, and cognitive enhancement treatments including Alzheimer's disease.